Cargando…

Neurological complications of breast cancer: study protocol of a prospective cohort study

INTRODUCTION: The improvement in breast cancer survival rates, along with the expected overdiagnosis and overtreatment associated with breast cancer screening, requires a comprehensive assessment of its burden. Neurological complications can have a devastating impact on these patients; neuropathic p...

Descripción completa

Detalles Bibliográficos
Autores principales: Pereira, Susana, Fontes, Filipa, Sonin, Teresa, Dias, Teresa, Fragoso, Maria, Castro-Lopes, José, Lunet, Nuno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212178/
https://www.ncbi.nlm.nih.gov/pubmed/25351600
http://dx.doi.org/10.1136/bmjopen-2014-006301
_version_ 1782341668028022784
author Pereira, Susana
Fontes, Filipa
Sonin, Teresa
Dias, Teresa
Fragoso, Maria
Castro-Lopes, José
Lunet, Nuno
author_facet Pereira, Susana
Fontes, Filipa
Sonin, Teresa
Dias, Teresa
Fragoso, Maria
Castro-Lopes, José
Lunet, Nuno
author_sort Pereira, Susana
collection PubMed
description INTRODUCTION: The improvement in breast cancer survival rates, along with the expected overdiagnosis and overtreatment associated with breast cancer screening, requires a comprehensive assessment of its burden. Neurological complications can have a devastating impact on these patients; neuropathic pain and chemotherapy-induced peripheral neuropathy are among the most frequently reported. This project aims to understand the burden of neurological complications of breast cancer treatment in Northern Portugal, and their role as mediator of the impact of the treatment in different dimensions of the patients’ quality of life. METHODS AND ANALYSIS: A prospective cohort study was designed to include 500 patients with breast cancer, to be followed for 3 years. The patients were recruited at the Portuguese Oncology Institute of Porto and evaluations were planned at different stages: pretreatment, after surgery, after chemotherapy (whenever applicable) and at 1 and 3 years after enrolment. Patients diagnosed with neuropathic pain or chemotherapy-induced peripheral neuropathy (subcohorts), were also evaluated at the moment of confirmation of clinical diagnosis of the neurological complication and 6 months later. In each of the follow-up periods, a neurological examination has been performed by a neurologist. Data were collected on sociodemographic and clinical characteristics, quality of life, sleep quality, and anxiety and depression. Between January and December 2012, we recruited and conducted the baseline evaluation of 506 participants. The end of the follow-up period is scheduled for December 2015. ETHICS AND DISSEMINATION: The study protocol was approved by the Ethics Committee of the Portuguese Oncology Institute of Porto and all patients provided written informed consent. All study procedures were developed in order to assure data protection and confidentiality. Results from this project will be disseminated in international peer-reviewed journals and presented in relevant conferences.
format Online
Article
Text
id pubmed-4212178
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-42121782014-10-31 Neurological complications of breast cancer: study protocol of a prospective cohort study Pereira, Susana Fontes, Filipa Sonin, Teresa Dias, Teresa Fragoso, Maria Castro-Lopes, José Lunet, Nuno BMJ Open Epidemiology INTRODUCTION: The improvement in breast cancer survival rates, along with the expected overdiagnosis and overtreatment associated with breast cancer screening, requires a comprehensive assessment of its burden. Neurological complications can have a devastating impact on these patients; neuropathic pain and chemotherapy-induced peripheral neuropathy are among the most frequently reported. This project aims to understand the burden of neurological complications of breast cancer treatment in Northern Portugal, and their role as mediator of the impact of the treatment in different dimensions of the patients’ quality of life. METHODS AND ANALYSIS: A prospective cohort study was designed to include 500 patients with breast cancer, to be followed for 3 years. The patients were recruited at the Portuguese Oncology Institute of Porto and evaluations were planned at different stages: pretreatment, after surgery, after chemotherapy (whenever applicable) and at 1 and 3 years after enrolment. Patients diagnosed with neuropathic pain or chemotherapy-induced peripheral neuropathy (subcohorts), were also evaluated at the moment of confirmation of clinical diagnosis of the neurological complication and 6 months later. In each of the follow-up periods, a neurological examination has been performed by a neurologist. Data were collected on sociodemographic and clinical characteristics, quality of life, sleep quality, and anxiety and depression. Between January and December 2012, we recruited and conducted the baseline evaluation of 506 participants. The end of the follow-up period is scheduled for December 2015. ETHICS AND DISSEMINATION: The study protocol was approved by the Ethics Committee of the Portuguese Oncology Institute of Porto and all patients provided written informed consent. All study procedures were developed in order to assure data protection and confidentiality. Results from this project will be disseminated in international peer-reviewed journals and presented in relevant conferences. BMJ Publishing Group 2014-10-28 /pmc/articles/PMC4212178/ /pubmed/25351600 http://dx.doi.org/10.1136/bmjopen-2014-006301 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Epidemiology
Pereira, Susana
Fontes, Filipa
Sonin, Teresa
Dias, Teresa
Fragoso, Maria
Castro-Lopes, José
Lunet, Nuno
Neurological complications of breast cancer: study protocol of a prospective cohort study
title Neurological complications of breast cancer: study protocol of a prospective cohort study
title_full Neurological complications of breast cancer: study protocol of a prospective cohort study
title_fullStr Neurological complications of breast cancer: study protocol of a prospective cohort study
title_full_unstemmed Neurological complications of breast cancer: study protocol of a prospective cohort study
title_short Neurological complications of breast cancer: study protocol of a prospective cohort study
title_sort neurological complications of breast cancer: study protocol of a prospective cohort study
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212178/
https://www.ncbi.nlm.nih.gov/pubmed/25351600
http://dx.doi.org/10.1136/bmjopen-2014-006301
work_keys_str_mv AT pereirasusana neurologicalcomplicationsofbreastcancerstudyprotocolofaprospectivecohortstudy
AT fontesfilipa neurologicalcomplicationsofbreastcancerstudyprotocolofaprospectivecohortstudy
AT soninteresa neurologicalcomplicationsofbreastcancerstudyprotocolofaprospectivecohortstudy
AT diasteresa neurologicalcomplicationsofbreastcancerstudyprotocolofaprospectivecohortstudy
AT fragosomaria neurologicalcomplicationsofbreastcancerstudyprotocolofaprospectivecohortstudy
AT castrolopesjose neurologicalcomplicationsofbreastcancerstudyprotocolofaprospectivecohortstudy
AT lunetnuno neurologicalcomplicationsofbreastcancerstudyprotocolofaprospectivecohortstudy